{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:32Z","timestamp":1791893072196,"version":"4.3.4"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005026","name":"Foundation Against Cancer","doi-asserted-by":"publisher","award":["F\/2024\/2554"],"award-info":[{"award-number":["F\/2024\/2554"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","award":["iBOF\/23\/014"],"award-info":[{"award-number":["iBOF\/23\/014"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.seminhematol.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:57:14Z","timestamp":1789570634000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defects in ribosomes and translational control in lymphoid leukemia and lymphoma"],"prefix":"10.1053","author":[{"given":"Marino","family":"Caruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomy","family":"Pasau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-9531","authenticated-orcid":false,"given":"Kim","family":"De Keersmaecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7549","key":"10.1053\/j.seminhematol.2026.09.002_bib0001","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature14427","article-title":"Structure of the human 80S ribosome","volume":"520","author":"Khatter","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/5951","article-title":"The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia","volume":"21","author":"Draptchinskaia","year":"1999","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0003","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41375-025-02599-2","article-title":"T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments","volume":"39","author":"Buckley","year":"2025","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"De Keersmaecker","year":"2013","journal-title":"Nat Genet"},{"issue":"18","key":"10.1053\/j.seminhematol.2026.09.002_bib0005","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1182\/blood-2012-03-415349","article-title":"Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B","volume":"120","author":"Rao","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0006","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"Tzoneva","year":"2013","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.09.002_bib0007","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0008","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0009","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3324\/haematol.2022.281196","article-title":"Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials","volume":"108","author":"Gonz\u00e1lez-Gil","year":"2023","journal-title":"Haematologica"},{"issue":"8027","key":"10.1053\/j.seminhematol.2026.09.002_bib0010","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1058468","article-title":"Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10","volume":"13","author":"Bacci","year":"2022","journal-title":"Front Genet"},{"issue":"15","key":"10.1053\/j.seminhematol.2026.09.002_bib0012","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1073\/pnas.1400247111","article-title":"Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis","volume":"111","author":"Sulima","year":"2014","journal-title":"PNAS"},{"issue":"Pt 1","key":"10.1053\/j.seminhematol.2026.09.002_bib0013","article-title":"Ribosomal protein L5 (RPL5\/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells","volume":"243","author":"Bacci","year":"2026","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/leu.2017.225","article-title":"The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling","volume":"32","author":"Girardi","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41375-018-0176-z","article-title":"The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL","volume":"33","author":"Kampen","year":"2019","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0016","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41467-019-10508-2","article-title":"Translatome analysis reveals altered serine\/glycine metabolism in T-cell acute lymphoblastic leukemia","volume":"10","author":"Kampen","year":"2019","journal-title":"Nat Commun"},{"issue":"5924","key":"10.1053\/j.seminhematol.2026.09.002_bib0017","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","article-title":"The ins and outs of serine and glycine metabolism in cancer","volume":"3","author":"Geeraerts","year":"2021","journal-title":"Nat Metabolism"},{"issue":"7360","key":"10.1053\/j.seminhematol.2026.09.002_bib0019","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41375-021-01361-8","article-title":"Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy","volume":"36","author":"Pikman","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garcia-Canaveras","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0023","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1535-7163.MCT-20-0480","article-title":"Repurposing the antidepressant Sertraline as SHMT inhibitor to suppress serine\/glycine synthesis-addicted breast tumor growth","volume":"20","author":"Geeraerts","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.09.002_bib0024","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41416-023-02216-y","article-title":"Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer","volume":"128","author":"Heylen","year":"2023","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/0008-5472.CAN-18-1987","article-title":"Ribosomal lesions promote oncogenic mutagenesis","volume":"79","author":"Sulima","year":"2019","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0026","first-page":"1969","article-title":"NKX2-1 regulates cell survival, maturation, and DNA-damage responses as a cofactor of RUNX1 in T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Aerschot","year":"2026","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.09.002_bib0027","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41594-025-01616-3","article-title":"Comparative CRISPRi screens reveal a human stem cell dependence on mRNA translation-coupled quality control","volume":"32","author":"Rodschinka","year":"2025","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.09.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003708","article-title":"The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1","volume":"9","author":"O'Leary","year":"2013","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0029","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.4049\/jimmunol.1600815","article-title":"Rpl22 Loss selectively impairs \u03b1\u03b2 T cell development by dysregulating endoplasmic reticulum stress signaling","volume":"197","author":"Solanki","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.1402242","article-title":"Rpl22 loss impairs the development of B lymphocytes by activating a p53-dependent checkpoint","volume":"194","author":"Fahl","year":"2015","journal-title":"J Immunol"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.09.002_bib0031","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1158\/0008-5472.CAN-15-2698","article-title":"Ribosomal protein Rpl22 controls the dissemination of T-cell lymphoma","volume":"76","author":"Rao","year":"2016","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70377","article-title":"A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defects","volume":"10","author":"Astier","year":"2026","journal-title":"Hemasphere"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0033","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.celrep.2015.09.038","article-title":"Partial loss of Rpl11 in adult mice recapitulates diamond-blackfan anemia and promotes lymphomagenesis","volume":"13","author":"Morgado-Palacin","year":"2015","journal-title":"Cell Rep"},{"issue":"50","key":"10.1053\/j.seminhematol.2026.09.002_bib0034","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.1073\/pnas.1218535109","article-title":"Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress","volume":"109","author":"Bursac","year":"2012","journal-title":"PNAS"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.09.002_bib0035","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1128\/MCB.23.23.8902-8912.2003","article-title":"Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"41","key":"10.1053\/j.seminhematol.2026.09.002_bib0036","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1038\/onc.2013.430","article-title":"Ribosomal proteins L5 and L11 co-operatively inactivate c-myc via RNA-induced silencing complex","volume":"33","author":"Liao","year":"2014","journal-title":"Oncogene"},{"issue":"17","key":"10.1053\/j.seminhematol.2026.09.002_bib0037","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1074\/jbc.M109.056259","article-title":"Ribosomal protein L11 associates with c-myc at 5 S rRNA and tRNA genes and regulates their expression","volume":"285","author":"Dai","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.09.002_bib0038","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.3324\/haematol.2016.162198","article-title":"Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma","volume":"102","author":"Hofman","year":"2017","journal-title":"Haematologica"},{"issue":"7339","key":"10.1053\/j.seminhematol.2026.09.002_bib0039","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.09.002_bib0041","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/leu.2016.370","article-title":"RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response","volume":"31","author":"Hofman","year":"2017","journal-title":"Leukemia"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.09.002_bib0042","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s43018-023-00657-1","article-title":"Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens","volume":"4","author":"Maura","year":"2023","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41408-024-01096-6","article-title":"Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma","volume":"14","author":"Ziccheddu","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.09.002_bib0044","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: a review","volume":"329","author":"Shadman","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.09.002_bib0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","article-title":"Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations","volume":"127","author":"Ljungstrom","year":"2016","journal-title":"Blood"},{"issue":"7574","key":"10.1053\/j.seminhematol.2026.09.002_bib0046","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"22","key":"10.1053\/j.seminhematol.2026.09.002_bib0047","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2017-09-804401","article-title":"Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia","volume":"132","author":"Bretones","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0048","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1002\/ajh.26239","article-title":"Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French Innovative Leukemia Organization","volume":"96","author":"Moulin","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0049","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-026-70655-1","article-title":"Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instability","volume":"17","author":"Gutierrez","year":"2026","journal-title":"Nat Commun"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0050","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/bloodadvances.2023012221","article-title":"BTK inhibitors in CLL: second-generation drugs and beyond","volume":"8","author":"Tam","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.09.002_bib0051","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2023023659","article-title":"Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib","volume":"144","author":"Woyach","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0052","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/15476286.2022.2064073","article-title":"The C-terminal tail of ribosomal protein Rps15 is engaged in cytoplasmic pre-40S maturation","volume":"19","author":"R\u00f6ssler","year":"2022","journal-title":"RNA Biol"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0053","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biochi.2010.02.031","article-title":"Eukaryote-specific motif of ribosomal protein S15 neighbors A site codon during elongation and termination of translation","volume":"92","author":"Khairulina","year":"2010","journal-title":"Biochimie"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0054","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/nar\/gkz1145","article-title":"Karpova GG: mRNA regions where 80S ribosomes pause during translation elongation in vivo interact with protein uS19, a component of the decoding site","volume":"48","author":"Babaylova","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.037","article-title":"Dynamics of uS19 C-terminal tail during the translation elongation cycle in Human ribosomes","volume":"31","author":"Bhaskar","year":"2020","journal-title":"Cell Rep"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.09.002_bib0056","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/bloodadvances.2020001717","article-title":"RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia","volume":"5","author":"Ntoufa","year":"2021","journal-title":"Blood Adv"},{"issue":"1921","key":"10.1053\/j.seminhematol.2026.09.002_bib0057","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0380","article-title":"Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions","volume":"380","author":"Caruso","year":"2025","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068667","article-title":"Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network","volume":"8","author":"Daftuar","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8818007","article-title":"Methylation of 45S ribosomal DNA (rDNA) is associated with cancer and aging in humans","volume":"2021","author":"Shao","year":"2021","journal-title":"Int J Genomics"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006994","article-title":"Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400232","article-title":"Assessing human ribosomal DNA variation and its association with phenotypic outcomes","volume":"47","author":"Rodriguez-Algarra","year":"2025","journal-title":"Bioessays"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1705","article-title":"Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies","volume":"14","author":"Cui","year":"2024","journal-title":"Clin Transl Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0064","article-title":"Diversity of ribosomes at the level of rRNA variation associated with human health and disease","volume":"4","author":"Rothschild","year":"2024","journal-title":"Cell Genom"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.09.002_bib0065","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1158\/0008-5472.CAN-09-2680","article-title":"Human rRNA gene clusters are recombinational hotspots in cancer","volume":"69","author":"Stults","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0066","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s42003-019-0284-y","article-title":"Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation","volume":"2","author":"Diesch","year":"2019","journal-title":"Commun Biol"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.09.002_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114037","article-title":"Myc as a regulator of ribosome biogenesis and cell competition: a link to cancer","volume":"21","author":"Destefanis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0068","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BS9.0000000000000073","article-title":"MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies","volume":"3","author":"Li","year":"2021","journal-title":"Blood Sci"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0069","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/10428194.2024.2447362","article-title":"The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia","volume":"66","author":"Ysebaert","year":"2025","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bcmd.2010.08.002","article-title":"The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma","volume":"45","author":"Smith","year":"2010","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0071","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ncb1224","article-title":"c-myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I","volume":"7","author":"Grandori","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"188","key":"10.1053\/j.seminhematol.2026.09.002_bib0072","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001754","article-title":"AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer","volume":"4","author":"Chan","year":"2011","journal-title":"Sci Signal"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0073","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-14-0673","article-title":"Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma","volume":"6","author":"Devlin","year":"2016","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0074","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.trecan.2016.03.002","article-title":"RP-MDM2-p53 pathway: linking ribosomal biogenesis and tumor surveillance","volume":"2","author":"Liu","year":"2016","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112333","article-title":"Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma","volume":"28","author":"Rossi","year":"2025","journal-title":"iScience"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0076","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1080\/15476286.2016.1259781","article-title":"Tuning the ribosome: the influence of rRNA modification on eukaryotic ribosome biogenesis and function","volume":"14","author":"Sloan","year":"2017","journal-title":"RNA Biol"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0077","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/cimb47090758","article-title":"Intracellular mis-localization of modified RNA molecules and non-coding RNAs: facts from hematologic malignancies","volume":"47","author":"Symeonidis","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0078","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.3390\/ijms24076334","article-title":"Specialized ribosomes in health and disease","volume":"24","author":"Miller","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"D1","key":"10.1053\/j.seminhematol.2026.09.002_bib0079","doi-asserted-by":"crossref","first-page":"D220","DOI":"10.1093\/nar\/gkz884","article-title":"snoDB: an interactive database of human snoRNA sequences, abundance and interactions","volume":"48","author":"Bouchard-Bourelle","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.2024028300","article-title":"Dynamic rRNA methylation regulates translation in the hematopoietic system and is essential for stem cell fitness","volume":"147","author":"Rabany","year":"2026","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0081","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/ajh.26989","article-title":"NPM1-mutated acute myeloid leukemia: new pathogenetic and therapeutic insights and open questions","volume":"98","author":"Falini","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0082","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719899818","article-title":"Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia","volume":"11","author":"Chen","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0083","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2009.07979.x","article-title":"Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia","volume":"148","author":"Rees-Unwin","year":"2010","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.09.002_bib0084","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41588-019-0502-z","article-title":"Germline NPM1 mutations lead to altered rRNA 2\u2032-O-methylation and cause dyskeratosis congenita","volume":"51","author":"Nachmani","year":"2019","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0085","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1182\/blood-2007-06-098251","article-title":"Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse","volume":"111","author":"Sportoletti","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0086","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaa035","article-title":"Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets","volume":"2","author":"Krogh","year":"2020","journal-title":"NAR Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0087","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0088","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/2159-8290.CD-22-0210","article-title":"A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia","volume":"13","author":"Zhou","year":"2023","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0089","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biom8020038","article-title":"Turning uridines around: role of rRNA pseudouridylation in ribosome biogenesis and ribosomal function","volume":"8","author":"Penzo","year":"2018","journal-title":"Biomolecules"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.148","article-title":"A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment","volume":"7","author":"Sbarrato","year":"2016","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0091","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41467-018-06523-4","article-title":"SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival","volume":"9","author":"Su","year":"2018","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102204","article-title":"Exploring the role of ribosomal RNA modifications in cancer","volume":"86","author":"L\u00f3pez","year":"2024","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107611","article-title":"Loss of m(1)acp(3)\u03a8 ribosomal RNA modification is a major feature of cancer","volume":"31","author":"Babaian","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0094","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"Sonenberg","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0096","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","article-title":"Targeting the eIF4F translation initiation complex: a critical nexus for cancer development","volume":"75","author":"Pelletier","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0097","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1053\/j.seminhematol.2026.09.002_bib0098","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Wendel","year":"2007","journal-title":"Genes Dev"},{"issue":"26","key":"10.1053\/j.seminhematol.2026.09.002_bib0099","first-page":"3166","article-title":"Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL","volume":"141","author":"Largeot","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0100","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41416-020-01205-9","article-title":"Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax","volume":"124","author":"Herzog","year":"2021","journal-title":"Br J Cancer"},{"issue":"430","key":"10.1053\/j.seminhematol.2026.09.002_bib0101","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad8463","article-title":"The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes","volume":"9","author":"So","year":"2016","journal-title":"Sci Signal"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003494","article-title":"Distinct translational control in CD4+ T cell subsets","volume":"9","author":"Bjur","year":"2013","journal-title":"PLoS Genet"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.09.002_bib0103","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3795","article-title":"Translation is actively regulated during the differentiation of CD8(+) effector T cells","volume":"18","author":"Araki","year":"2017","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0104","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)65118-8","article-title":"Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas","volume":"155","author":"Wang","year":"1999","journal-title":"Am J Pathol"},{"issue":"18","key":"10.1053\/j.seminhematol.2026.09.002_bib0106","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/sj.onc.1207545","article-title":"eIF-4E expression and its role in malignancies and metastases","volume":"23","author":"De Benedetti","year":"2004","journal-title":"Oncogene"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.09.002_bib0107","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41388-018-0567-7","article-title":"Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia","volume":"38","author":"Urtishak","year":"2019","journal-title":"Oncogene"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0108","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.2024025484","article-title":"The GATA-3-dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas","volume":"145","author":"Kady","year":"2025","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102748","article-title":"Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function","volume":"24","author":"Chiu","year":"2021","journal-title":"iScience"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.09.002_bib0110","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1158\/1078-0432.CCR-12-2185","article-title":"Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia","volume":"19","author":"Willimott","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10020-022-00534-0","article-title":"Gartenhaus RB: novel eIF4A1 inhibitors with anti-tumor activity in lymphoma","volume":"28","author":"Kayastha","year":"2022","journal-title":"Mol Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0112","first-page":"2651","article-title":"Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model","volume":"118","author":"Bordeleau","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.09.002_bib0113","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41375-018-0364-x","article-title":"Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia","volume":"33","author":"Chen","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.09.002_bib0114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1208\/s12248-011-9276-7","article-title":"Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1\/P-glycoprotein overexpression in acute lymphoblastic leukemia cells","volume":"13","author":"Gupta","year":"2011","journal-title":"AAPS J"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.09.002_bib0115","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2013.295","article-title":"A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma","volume":"28","author":"Horvilleur","year":"2014","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.09.002_bib0116","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","article-title":"Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism","volume":"13","author":"Gingras","year":"1999","journal-title":"Genes Dev"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0117","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20070024","article-title":"Signalling to translation: how signal transduction pathways control the protein synthetic machinery","volume":"403","author":"Proud","year":"2007","journal-title":"Biochem J"},{"issue":"22","key":"10.1053\/j.seminhematol.2026.09.002_bib0118","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2015-02-629485","article-title":"4EBP1\/c-MYC\/PUMA and NF-\u03bab\/EGR1\/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells","volume":"127","author":"Yun","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.09.002_bib0119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large BCell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.09.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059335","article-title":"Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)","volume":"8","author":"Nemes","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1053\/j.seminhematol.2026.09.002_bib0121","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.18632\/oncotarget.4104","article-title":"RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia","volume":"6","author":"Shull","year":"2015","journal-title":"Oncotarget"},{"issue":"15","key":"10.1053\/j.seminhematol.2026.09.002_bib0122","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","article-title":"Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development","volume":"24","author":"Ueda","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"32","key":"10.1053\/j.seminhematol.2026.09.002_bib0123","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1073\/pnas.1008136107","article-title":"Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development","volume":"107","author":"Ueda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"10.1053\/j.seminhematol.2026.09.002_bib0124","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/onc.2014.146","article-title":"Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3","volume":"34","author":"Robichaud","year":"2015","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/OTT.S370874","article-title":"MNK proteins as therapeutic targets in leukemia","volume":"16","author":"Mazewski","year":"2023","journal-title":"Onco Targets Ther"},{"key":"10.1053\/j.seminhematol.2026.09.002_bib0126","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/ncomms6413","article-title":"MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL","volume":"5","author":"Landon","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.09.002_bib0127","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41401-018-0161-0","article-title":"MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells","volume":"39","author":"Huang","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/leu.2015.180","article-title":"Discovery of a BTK\/MNK dual inhibitor for lymphoma and leukemia","volume":"30","author":"Wu","year":"2016","journal-title":"Leukemia"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.09.002_bib0129","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1053\/j.seminhematol.2026.09.002_bib0130","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2026.09.002_bib0131","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.09.002_bib0132","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course","volume":"91","author":"Put","year":"2012","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.09.002_bib0133","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat Med"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.09.002_bib0134","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-07-5876","article-title":"c-Myc and eIF4F are components of a feedforward loop that links transcription and translation","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res"},{"issue":"6292","key":"10.1053\/j.seminhematol.2026.09.002_bib0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.aad9868","article-title":"Translational control by 5\u2032-untranslated regions of eukaryotic mRNAs","volume":"352","author":"Hinnebusch","year":"2016","journal-title":"Science"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.09.002_bib0136","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.15252\/embr.201540717","article-title":"Myc coordinates transcription and translation to enhance transformation and suppress invasiveness","volume":"16","author":"Elkon","year":"2015","journal-title":"EMBO Rep"},{"issue":"7510","key":"10.1053\/j.seminhematol.2026.09.002_bib0137","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature13537","article-title":"Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis","volume":"511","author":"Sab\u00f2","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.09.002_bib0138","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"issue":"29","key":"10.1053\/j.seminhematol.2026.09.002_bib0139","doi-asserted-by":"crossref","first-page":"11988","DOI":"10.1073\/pnas.1310230110","article-title":"Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers","volume":"110","author":"Pourdehnad","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:30:04Z","timestamp":1791891004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":139,"alternative-id":["S0037196326000879"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.09.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defects in ribosomes and translational control in lymphoid leukemia and lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}